Physical, intellectual and genetic characteristics of 53 neonates with phenylketonuria
LIU Liying1, KANG Wenjuan2,3, DONG Qin2, ZHANG Xiaogang2, YAN Yaqiong1
1. School of Public Health, Shanxi Medical University, Taiyuan, Shanxi 030001, China; 2. Shanxi Children's Hospital (Shanxi Maternal and Child Health Hospital), Taiyuan, Shanxi 030013, China; 3. Shanxi Clinical Medical Research Center for Birth Defects and Rare Diseases, Taiyuan, Shanxi 030013, China
Abstract：Objective To investigate the physical and intellectual development and mutation characteristics of the phenylalanine hydroxylase (PAH) gene among 53 newborns with phenylketonuria (PKU), so as to provide insights into the management and genetic counseling of PKU. Methods The medical records of 54 children with definitive diagnosis of PKU and standardized therapy until 2 years at the Center for Neonatal Disease Screening of Shanxi Children' s Hospital from 2018 to 2021 were collected. Newborns' body weight and height developments were evaluated using the World Health Organization growth chart (2006 version), and the intellectual development was assessed using the national criteria of Development Behavior Assessment Scale among Children at Ages of 0 to 6 Years (WS/T 580-2017). The gene mutations were detected among neonates and their children, and the physical, intellectual developments and genetic characteristics of neonates with PKU were descriptively analyzed. Results The 53 PKU cases included 29 male children and 24 female children, 36 cases with classic PKU and 17 cases with mild PKU, and 30 cases from rural areas and 23 cases from urban areas. The study subjects had a median age of 30 (10) d at initial therapy, and a mean blood phenylalanine concentration of (1 507±685) μmol/L at definitive diagnosis. There were 52 cases with normal height developments (98.11%), and all cases had normal weight and intellectual developments. The mean developmental functional quotient (DFQ) was significantly greater among urban children with PKU than among rural children [(94.92±8.57) vs. (87.65±6.57); t=-3.498, P=0.001], and the mean DFQ was significantly higher among children with mild PKU than among those with classic PKU [(95.55±8.76) vs. (88.57±7.11); t=-3.095, P=0.003]. There were 37 mutations detected in the PAH gene, which were mainly distributed in exons 3, 6, 7, 11, 12 and intron 4. Three high-frequency mutation sites were detected, including c.728G>A, c.611A>G and c.1197A>T, including three novel mutations (c.674C>G, c.1316-2A>C and c.1069T>C). Conclusions Following standardized treatment, the children with PKU have comparable physical and intellectual developments as compared to normal children. c.728G>A, c.611A>G and c.1197A>T were predominant mutations in the PAH gene among these 53 children with PKU, and three novel mutations were identified, including c.674C>G, c.1316-2A>C and c.1069T>C.
[1] COUCE M L,SÁNCHEZ-PINTOS P,VITORIA I,et al.Carbohydrate status in patients with phenylketonuria[J/OL].Orphanet J Rare Dis,2018,13(1)[2022-07-27].https://doi.org/10.1186/s13023-018-0847-x. [2] VAN SPRONSEN F J,BLAU N,HARDING C,et al.Phenylketonuria[J/OL].Nat Rev Dis Primers,2021,7(1)[2022-07-27].https://doi.org/10.1038/s41572-021-00267-0. [3] 裴晶晶,王冉,郭冰冰,等.41例苯丙酮尿症患儿饮食治疗效果评估[J].中国儿童保健杂志,2020,28(7):780-783. PEI J J,WANG R,GUO B B,et al.Evaluation of dietary therapy in 41 children with phenylketonuria[J].Chin J Child Health Care,2020,28(7):780-783. [4] 朱玲,杨建平,董勤,等.97例苯丙酮尿症患儿的治疗效果[J].中华围产医学杂志,2015,18(3):200-203. ZHU L,YANG J P,DONG Q,et al.Outcomes of 97 cases of phenylketonuria[J].Chin J Perinal Med,2015,18(3):200-203. [5] THIELE A G,GAUSCHE R,LINDENBERG C,et al.Growth and final height among children with phenylketonuria[J/OL].Pediatrics,2017,40(5)[2022-07-27].https://doi.org/10.1542/peds.2017-0015. [6] 杨茹莱,沈亚平,陈迟,等.2009—2021年浙江省新生儿遗传代谢病基因型分析[J].预防医学,2022,34(8):760-764. YANG R L,SHEN Y P,CHEN C,et al.Genotypes and prognosis of inherited metabolic diseases in Zhejiang Province from 2009 to 2021[J].Prev Med,2022,34(8):760-764. [7] 王冬娟,张娟,刘浩,等.重庆部分地区苯丙氨酸羟化酶缺乏症患儿基因突变分析[J].第三军医大学学报,2021,43(9):876-882. WANG D J,ZHANG J,LIU H,et al.Gene mutations in children with phenylalanine hydroxylase deficiency:an analysis of 45 cases in some regions of Chongqing[J].Acta Acad Med Mil Ter,2021,43(9):876-882. [8] 中华预防医学会出生缺陷预防与控制专业委员会新生儿筛查学组,中华医学会儿科学分会临床营养学组,中国医师协会医学遗传医师分会临床生化遗传专业委员会,等.苯丙氨酸羟化酶缺乏症饮食治疗与营养管理共识[J].中华儿科杂志,2019,57(6):405-409. [9] 吕金峰,候方,王伟青,等.2013—2019年青岛市新生儿高苯丙氨酸血症筛查情况及基因突变分析[J].山东医药,2020,60(23):76-78. LÜ J F,HOU F,WANG W Q,et al.Hyperphenylalaninemia screening and gene mutation analysis among newborns in Qingdao City from 2013 to 2019[J].Shandong Med J,2020,60(23):76-78. [10] WHO Multicentre Growth Reference Study Group.WHO Child Growth Standards based on length/height,weight and age[J].Acta Paediatr,2006,95(Suppl.450):76-85. [11] 霍亭竹,毛萌.儿童体格生长评价相关问题[J].中华儿科杂志,2019,57(2):158-160. HUO T Z,MAO M.Common problems in child growth assessment[J].Chin J Pediatr,2019,57(2):158-160. [12] 中华人民共和国国家卫生和计划生育委员会.0岁~6岁儿童发育行为评估量表:WS/T 580—2017[S].2017. National Health and Family Planning Commission of the People's Republic of China.Developmental scale for children aged 0-6 years:WS/T 580-2017[S].2017. [13] VAN WEGBERG A M J,MACDONALD A,AHRING K,et al.The complete European guidelines on phenylketonuria:diagnosis and treatment[J/OL].Orphanet J Rare Dis,2017,12(1)[2022-07-27].https://doi.org/10.1186/s13023-017-0685-2. [14] 朱玲,杨建平,董勤,等.山西省新生儿疾病筛查中心十年苯丙酮尿症患儿治疗效果评估[J].中华全科医师杂志,2018,17(3):197-201. ZHU L,YANG J P,DONG Q,et al.Outcomes of children with phenylketonuria detected by newborn screening program[J].Chin J Gen Pract,2018,17(3):197-201. [15] ALIBAKHSHI R,MOHAMMADI A,SALARI N,et al.Spectrum of PAH gene mutations in 1 547 phenylketonuria patients from Iran:a comprehensive systematic review[J].Metab Brain Dis,2021,36(5):767-780. [16] 张亚果,叶飘,欧明才,等.四川省部分地区43例高苯丙氨酸血症患儿相关基因突变分析[J].中国儿童保健杂志,2020,28(11):1255-1258,1262. ZHANG Y G,YE P,OU M C,et al.Genetic analysis of 43 children with hyperphenylalaninemia in some regions of Sichuan[J].Chin J Child Health Care,2020,28(11):1255-1258,1262. [17] 侯丽青,冀云鹏,朱博,等.内蒙古地区汉族PKU患儿苯丙氨酸羟化酶基因突变分析[J].中国妇幼健康研究,2020,31(4):464-469. HOU L Q,JI Y P,ZHU B,et al.Analysis of mutation in phenylalanine hydroxylase gene in the Han ethnic group in Inner Mongolia[J].Chin J Woman Child Health Res,2020,31(4):464-469. [18] WANG X,WANG Y,MA D,et al.Neonatal screening and genotype-phenotype correlation of hyperphenylalaninemia in the Chinese population[J/OL].Orphanet J Rare Dis,2021,16(1)[2022-07-27].https://doi.org/10.1186/s13023-021-01846-w.
